ONLINE REGISTRATION IS ALREADY CLOSED - YOU CAN REGISTER ONSITE FROM SEPTEMBER 14th

ABSTRACT SUBMISSION AND POSTERS INSTRUCTIONS

CLICK HERE TO ACCESS THE LIST OF POSTER PRESENTATION PER DAY

  • POSTERS INSTRUCTIONS
 
DAY OF PRESENTATION:

September 15, Monday - Posters
P01-1 to 9; P02-1; P04-1 to 6; P07-1 to 4; P11-1 to 6; P12-1 to 3; P15-1 to 3; P16-1 to 6; P18-1 to 5; P20-1 to 3; P22-1 to 10; P28-1 to 18

September 16, Tuesday - Posters
P03-1; P06-1 to 5; P10-1 to 8; P13-1 to 6; P17-1 to 3; P18-6 to 10; P19-1 to 7; P21-1 to 5; P22-11 to 21; P23-1 to 4; P28-19 to 37

September 17, Wednesday - Posters
P01-10 to 17; P05-1 to 2; P06-6 to 9; P08-1 to 4; P09-1 to 5; P14-1 to 2; P16-7 to 11; P24-1 to 10; P25-1 to 2; P26-1 to 2; P27-1 to 3; P28-38 to 59; P29-1; P30-1 to 3; P31-1 to 2.


The poster should have the following dimensions: 0.90 m wide and 1.30 m high. A font size that allows reading at 1.5 m distance is suggested.

Presentation: Title in bold should be the same as the submitted abstract. Please include authors and Institution (Department, Institute, Hospital Unit, City, State and Country).

The posters must be hanged at the Poster Area – Copacabana Room – before 11 am of the day informed above, and removed the same evening after at the end of the scientific sessions.

The organization will not collect and keep Posters that are left on the Boards.

Poster numbers will be identified on the boards. It is preferable, and quicker, if posters are prepared to be hanged, but if necessary, tapes will be available onsite.

Please bring with you a pen drive containing a 5 min power point presentation of your work, in case your poster is selected for oral presentation. You must be present when specialists visit your poster at lunchtime. If the title and number of your poster are displayed at the entrance of the Poster Room after lunchtime, please deliver your presentation at the midia desk, informing the number of your poster.

We would like to remind you that the presenter must be registered in the Congress.
 
  • CALL FOR ABSTRACTS

It is recognised by ICN 2014 Committees that submitted abstracts are of prime importance for presentation of original data. Abstracts are to be submitted primarily for presentation as Poster and may derive from the full spectrum of neuropathology and neighbouring fields. The program committee will select the best abstracts to be presented not only as poster, but also as a short oral communication. The abstracts should be submitted in English not later than Wednesday, June 18, 2014, midnight Greenwich Mean Time -3 (GMT-3). Abstracts submitted after this deadline cannot be accepted, as the time schedule for printing the abstract issue of the journal is very tight.

The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat, and of all communications thereafter.

Only abstracts of registered participating authors will be accepted and included in a special Sept. 2014 online issue of BRAIN PATHOLOGY supplement with ICN 2014 abstracts.


ABSTRACT TOPICS

Abstracts must be allocated to a specific topic for the Scientific Program. Please choose one from the list of topics.

1. Cell biology & pathology
2. Systems & pathology
3. Alzheimer and related
4. Non-Alzheimer dementia
5. Parkinson and related
6. Motor neuron disease and related
7. Ataxia and related
8. Prion
9. Neurodegeneration, other and general
10. Tumors
11. Pediatric tumors
12. Vascular
13. Inflammation
14. Infection, viral
15. Infection, non-viral
16. Myelin disease
17. Epilepsy
18. Trauma
19. Psychosis
20. Stem cells and repair
21. Metabolic
22. Mitochondrial
23. Neurodevelopment
24. Behavioral
25. Peripheral nerve
26. Vegetative
27. Ophthalmic
28. Muscle
29. Clinical
30. Disease model
31. Methods and techniques
32. Neuroanatomy
33. History and Teaching
34. Veterinary
35. Varia

SUBMISSION OF ABSTRACTS

Abstracts should be submitted only via the online submission link. Please submit your abstract in the link ABSTRACT SUBMISSION in this webpage. Please note that - in order to access the Abstract Tool - you will need to fill your email address and the Password that you will fill in during registration. Only abstracts submitted via the website of ICN 2014 will be sent to the Scientific Committee for review. Abstracts submitted by fax will not be accepted. If you do not have access to the internet, please contact the ICN 2014 Secretariat.

Instructions on the preparation of posters and information regarding projection facilities will be included with the notification of acceptance.

Please follow the instructions on the website step by step. Please do not submit multiple copies of the same abstract.

You will receive confirmation that your abstract has been forwarded for review.

Please refer to the abstract number in all correspondence regarding the abstract.

PREPARATION OF PRESENTATIONS

Instructions for preparation of posters will be sent together with acceptance notifications and Poster number.

The ICN 2014 program includes dedicated poster sessions with oral presentations.

RULES FOR SUBMISSION

The first author is expected to attend ICN 2014 and present the poster and eventually give a short oral presentation if selected by the Scientific Committee.

All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor prior to submission.
Only abstracts of authors, who have paid their Registration Fee, and are submitted by June 18, 2014 will be accepted and be eligible for eventual oral presentation and included in the special online issue of BRAIN PATHOLOGY with ICN 2014 abstracts.


GUIDELINES FOR SUBMISSION

Abstracts should be no longer than 250 words. [PDF is not acceptable, only Word]

Author names should be explicit: to minimise ambiguity it is required that names start with first names given in full, middle as initials, and then last (family) (sur)names.

Abstracts should be structured as:

• Title (do not capitalize throughout but capitalize title words)
• Author name(s): give first in full, middle initial(s), and surname
• Affiliation/Address
• Abstract text. Please do not use more than 250 words. If you do, your abstract will appear truncated in the Abstract Book.

The abstract should arrive either as one paragraph, or in four sections;

• Introduction
• Patients (or Materials) and Methods
• Results
• Conclusion.

Figures should not be supplied. Tables should be provided only when absolutely essential and should be simple.

• Tables should be supplied as Tab-spaced text (not key-spaced), or as Word tables, i.e. not pasted in from other applications
• Carriage returns should not be used within cells
• Tables will be reduced to one column width.

Please ensure that all special characters/symbols are retained in the electronic copy. Take care not to use I (cap i) or l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for b (beta).

If references are essential, they should be within the text, in the form: (Silva et al. BJU Int 2013; 95: 27-30).

DISCLOSURES

The Organizing Committee has an obligation to request specific disclosures from abstract authors/submitters. Please be sure to include this information before submitting an abstract.

DISCLOSURES OF FACULTY RELATIONSHIPS & POLICY STATEMENT


The Conference requires that audiences be informed of a presenter’s academic and professional affiliations, as well as other commercial relationships relevant to the content of the material that is presented. This policy allows the listener/attendee to be fully informed regarding any possible conflict of interest in evaluating the information being presented. These situations may include, but are not limited to 1) stock options or bond holdings, 2)research grants from nonpublic sources, 3) employment (full or part time), 4) ownership or partnership, 5) consulting fees or other remuneration received by the presenter or his/her immediate family, 6) non-remunerative (nonremuneration?) positions of influence such as officer, board member, trustee or public spokesperson. The disclosure should be shown (by an* in the authors list) for those presenters who have stated that a relationship(s) exists relevant to the topic(s) to be discussed.

M2BR